SANUWAVE Health Inc. cash flow to debt ratio of 16.87% indicates that the company cannot generate enough cash to cover its debt over time. This level indicates weak financial health.

SANUWAVE Health Inc.'s free cash flow has decreased -1.58% from $1.97M last year to $1.93M, signaling decreasing performance

SANUWAVE Health Inc.'s debt to equity ratio is 12.06, which means that the company's assets are unhealthy financed, signaling financial risk. READ MORE: A ratio over 0.60 means the company finances its assets with debt, signaling financial risk. If ratio is negative, the company spent its own equity and risks bankruptcy

SANUWAVE Health Inc.'s debt has increased relative to shareholder equity from -2.00 last year to 12.06 today, signaling weakened financials

SANUWAVE Health Inc. has a net debt to EBITDA ratio of 0.57x, which is below the 3.00x threshold, indicating healthy leverage and financial stability

SANUWAVE Health Inc.'s interest coverage ratio is 0.57, which means that the company struggles to meet interest obligations, signaling financial risk.

SANUWAVE Health Inc.'s profit margin has increased (-137.66%) in the last year from -96.13% to 36.21%, signaling increasing performance

SANUWAVE Health Inc.'s short-term assets of $24.63M exceed its short-term liabilities of $17.85M

SANUWAVE Health Inc.'s return on assets of 43.26% is higher than the 5.00% threshold, indicating efficient asset utilization

SANUWAVE Health Inc.'s return on equity of -450.56%, is lower than 15.00%, indicating bad performance

SANUWAVE Health Inc.'s operating cash flow is lower than its net income, indicating that earnings may not be fully backed by cash generation

SANUWAVE Health Inc. had positive net income in only 1.00 out of 5 years, indicating unstable earnings

SANUWAVE Health Inc. has positive free cash flow, indicating the company generates cash after capital expenditures

SANUWAVE Health Inc. has a free cash flow yield of 1.88%, which is below the 2.00% threshold, indicating limited cash return relative to market value

SANUWAVE Health Inc.'s yearly earnings has increased -137.65% since last year from $-31.37M to $11.81M, signaling increasing performance

SANUWAVE Health Inc.'s yearly revenue has increased 34.98% since last year from $32.63M to $44.05M, signaling increasing performance

ROIC 11.43% (Source: FMP key-metrics). At or above the 10% threshold. Score: 2 of 2. The company is generating returns above the upper end of the typical US weighted-average cost of capital range under this definition of invested capital.

SANUWAVE Health Inc.'s 3-year revenue CAGR of 38.05% is positive, indicating growing revenue over the past 3 years

SANUWAVE Health Inc. had revenue growth in 5.00 out of 5 years, indicating consistent revenue performance

SANUWAVE Health Inc. had positive ROE in only 1.00 out of 5 years, indicating inconsistent returns on equity

SANUWAVE Health Inc. has insufficient data to evaluate this check.

SANUWAVE Health Inc. has an earnings yield of 15.62%, which is above the 4.00% threshold, indicating the stock offers reasonable value relative to its earnings

SANUWAVE Health Inc. is overvalued relative to its fair value price of 3.80 based on EBITDA multiple model

SANUWAVE Health Inc. has an EV/EBITDA ratio of 5.86x, which is below the 20.00x threshold, indicating reasonable valuation relative to its operating earnings

SANUWAVE Health Inc. is overvalued relative to its fair value price of -2.49 based on Earnings Fair Value model

SANUWAVE Health Inc. has a PEG-ratio under 1 which is considered undervalued

SANUWAVE Health Inc. has a price-to-book ratio of 55.91x, which exceeds the 5.00x threshold, indicating the stock may be overvalued relative to its book value

SANUWAVE Health Inc. has a price-to-sales ratio of 2.32x, which is below the 8.00x threshold, indicating reasonable valuation relative to its revenue